Zobrazeno 1 - 10
of 29
pro vyhledávání: '"John Silberholz"'
Publikováno v:
Management Science. 68:1982-2002
The success of a new drug is assessed within a clinical trial using a primary endpoint, which is typically the true outcome of interest—for example, overall survival. However, regulators sometimes approve drugs using a surrogate outcome—an interm
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
SSRN Electronic Journal.
Autor:
Colin Pawlowski, Dimitris Bertsimas, Jack Dunn, Alexander M. Weinstein, Ying Daisy Zhuo, Aymen A Elfiky, John Silberholz, Eddy Chen
Publikováno v:
JCO Clinical Cancer Informatics. :1-11
Purpose With rapidly evolving treatment options in cancer, the complexity in the clinical decision-making process for oncologists represents a growing challenge magnified by oncologists’ disposition of intuition-based assessment of treatment risks
Publikováno v:
Pediatrics. 147
BACKGROUND AND OBJECTIVES: Most transgender individuals assigned female at birth use chest binding (ie, wearing a tight garment to flatten chest tissue for the purpose of gender expression), often beginning in adolescence, to explore their gender ide
Autor:
Di Wu, John Silberholz
Publikováno v:
SSRN Electronic Journal.
A large segment of cryptoassets consists of tokens—simple code running on programmable blockchains such as Ethereum—that serve as a payment or governance mechanism for an underlying digital platform, usually a peer-to-peer marketplace of various
Publikováno v:
SSRN Electronic Journal.
Since March 2020, numerous models have been developed to support policymakers in understanding, forecasting, and controlling the COVID-19 pandemic. Differences in data, assumptions, and underlying theory, coupled with unknowns about a novel virus, le
Publikováno v:
INFORMS Journal on Computing. 30:608-624
Though empirical testing is broadly used to evaluate heuristics, there are shortcomings with how it is often applied in practice. In a systematic review of Max-Cut and quadratic unconstrained binary optimization (QUBO) heuristics papers, we found onl
Publikováno v:
Cancer Research. 78:P3-15
Background: Given the rapidly expanding size of the clinical trial literature for metastatic breast cancer (MBC) clinical trials, oncologists need tools that enable them to efficiently review the settings and results of previous studies. Methods: We
Publikováno v:
Springer US
Purpose Oncologists, clinical trialists, and guideline developers need tools that enable them to efficiently review the settings and results of previous studies testing metastatic breast cancer (MBC) drug therapies. Methods We searched the literature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c49e8976d9af10bf91ea8df7cbc215ce
https://hdl.handle.net/1721.1/131911
https://hdl.handle.net/1721.1/131911